https://www.selleckchem.com/pr....oducts/dir-cy7-dic18
Huntington's disease (HD) is a severe neurodegenerative disorder with no effective treatment. Minimally-invasive biomarkers such as blood neurofilament light chain (NfL) in HD are therefore needed to quantitatively characterize neuronal loss. NfL levels in HD are known to correlate with disease progression and striatal atrophy, but whether they also reflect cortical degeneration remains elusive. In a sample of 35 HD patients, we characterized the cortical macro (cortical thickness) and microstructural (increased intracortical diff
Like
Comment
Share
